FDX1 and nonpapillary renal cell carcinoma: The results revealed that there was a positive correlation between the FDX1 IHC score and the CD4+ T cell population (Figure 5D,E), strengthening the notion that the CD4+ T cell immune response may be strongly responsive to FDX1-mediated cuproptosis in ccRCC.